Angiogenin—A Proposed Biomarker for Cardiovascular Disease—Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease

We evaluated angiogenin as a prospective biomarker in peripheral artery disease (PAD) patients with and without claudication symptoms. A pilot study suggested an elevation of angiogenin in critical limb ischemia. However, in PAD patients, the predictive value of angiogenin has not yet been evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Höbaus, Clemens, Pesau, Gerfried, Zierfuss, Bernhard, Koppensteiner, Renate, Schernthaner, Gerit-Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Peripheral Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436295/
https://www.ncbi.nlm.nih.gov/pubmed/33779308
http://dx.doi.org/10.1177/00033197211004393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436295/
https://www.ncbi.nlm.nih.gov/pubmed/33779308
http://dx.doi.org/10.1177/00033197211004393

Ejemplares similares